Tracy L. Skaer, Pharm.D.

Education
Doctor of Pharmacy, University of Southern California

Bachelor of Pharmacy, Washington State University

Licensure
Dr. Tracy Skaer is a licensed pharmacist in Washington, Idaho, California, and South Carolina.

Fellowships & Additional Training
American Society of Health System Pharmacists Residency in Hospital Pharmacy, Richland Memorial Hospital

Fellow of the American Board of Forensic Examiners (FABFE)

ABFE Certified Forensic Consultant (CFC)

Fellow of the American Society of Health-System Pharmacists (FASHP)

Fellow of the American Society of Consultant Pharmacists (FASCP)

Research Interests
Skaer's research interests focus on issues involving mental health, comorbidities in chronic illness, chronic pain, complementary and alternative medicine, pharmacoeconomics, and pharmacoepidemiology. Her research has been supported by over $3.2 million in grants from foundations and the pharmaceutical industry. Dr. Skaer's research and reviews (over 100 publications) have appeared in numerous high-tiered peer review journals and textbooks.

Skaer’s current research involves the use of mindfulness and multiple family group problem solving for the treatment of chronic pain in those with high risk of opioid use. Her plans are to expand this intervention to manage chronic insomnia and post-traumatic stress disorder in children and adolescents, American Indians, veterans, and other populations.

Selected Publications
Skaer TL, Kwong J. Illness Perceptions and Burden of Disease in Fibromyalgia. Expert Review of Pharmacoeconomics & Outcomes Research. 2017;17(1):9-15. Read Here

Skaer TL. Treatment Recommendations for Fibromyalgia. International Journal of Pharma Research & Review. 2016;5(4):19-28. Read Here

Skaer TL, Nwude AC. Opioid Prescribing Laws and Emergency Department Guidelines for Chronic Non-Cancer Pain in Washington State. Pain Practice. 2016;16(5);642-647. Read Here

Skaer TL Research Findings Using Mindfulness-Based Interventions for Chronic Pain. Pain Studies and Treatment. 2015;3(4):38-45. Read Here

Skaer TL. Fibromyalgia: Disease Synopsis, Medication Cost-Effectiveness, and Economic Burden. PharmacoEconomics 2014;32(5):457-66.

Skaer TL. Dosing Considerations with Transdermal Formulations of Fentanyl and Buprenorphine for the Treatment of Cancer Pain. Journal of Pain Research. 2014;7:495-503. Online Open Access: Read Here

Skaer TL, Nwude A, Male Ervik AL. Sleep Disturbance and Suicide Risk in the Elderly. Journal of Sleep Disorders and Therapy. 2014;3(5):181. Online Open Access: Read More

Skaer TL, Male Ervik AL, Nwude A. Mindfulness-Based Therapy for Chronic Insomnia. Journal of Sleep Medicine and Disorders. 2014;1(2):1007. Online Open Access: Read More

Skaer TL, Chapter 19: Sleep Deprivation and Economic Burden. In Sleep Deprivation and Disease: Effects on the Body, Brain and Behavior. Bianchi MT (ed), Massachusetts General Hospital Division of Sleep Medicine, Springer. 2013

Skaer TL, Chapter 6: Treatment of Insomnia with Comorbid Mental Illness. In: Can’t Sleep? Issues of Being an Insomniac [ISBN 978-953-307-763-5], Online open access textbook, InTech. DOI: 10.5772/32324; 03/2012. [10/13/13 – download 1,500 times since publication]

Sclar DA, Robison LM, Skaer TL, et al. Concomitant Use of a triptan and SSRI or SNRI After the US Food and Drug Administration Alert on Serotonin Syndrome. Headache 2012:52(2):198-203.

Skaer TL, Sclar DA. Economic Implications of Sleep Disorders. PharmacoEconomics 2010;11:1015-1023.

Skaer TL, Odell, C. Chapter 34: Mental Health. In: Women's Health Across the Lifespan: A Pharmacotherapeutic Approach. Bethesda, Maryland USA, Borgelt CM, O’Connell, MB, Smith JA, Calis KA, Editors. American Society of Health Systems Pharmacists. 2010:533-544.

Skaer TL, Odell, C. Chapter 34: Mental Health. In: Women's Health Across the Lifespan: A Pharmacotherapeutic Approach. Bethesda, Maryland USA, Borgelt CM, O’Connell, MB, Smith JA, Calis KA, Editors. American Society of Health Systems Pharmacists. 2010:533-544.

Skaer TL, Sclar DA, Robison Trend in Anxiety Disorders in the United States 1990-2003. Primary Care and Community Psychiatry 2008;13(1):1-7.

Skaer TL, Sclar DA. Anxiety Disorders in Women Part 2: Pharmacotherapy. The Female Patient 2006:31(8):23-28.

Skaer TL, Sclar DA. Anxiety Disorders in Women Part 1: Prevalence, Trends, and Psychotherapy. The Female Patient 2006:31(7):20-27.

Skaer TL, Use of Transdermal Opioids for Cancer Pain. Health and Quality of Life Outcomes, 2006;4(24):1-15. Open access journal: http://www.hqlo.com/content/4/1/24 “Highly accessed”

Cloutier S, Skaer TL, Newberry RC. Consumption of Alcohol by Sows in a Choice Test. Physiology and Behavior 2006;88:101-107.

Robison LM, Sclar DA, Skaer TL.Trends in ADHD and Stimulant Use among U.S. Adults: 1995-2002. Psychiatric Services 2005;56(12):1497.

Skaer TL. Practice Guidelines for Transdermal Opioids in Malignant Pain. Drugs 2004,64(23): 2629-2638.

Robison LM, Skaer TL, Sclar DA, Galin RS. Is Attention-Deficit / Hyperactivity Disorder Increasing Among Girls in the U.S.? Trends in Diagnosis and the Prescribing of Stimulants. CNS Drugs 2002;16(2):129-137.

Skaer TL, Sclar DA, Robison LM. Complaint of Insomnia in the United States 1995-1998: Prevalence, Psychiatric Comorbidity, and Pharmacologic Treatment Patterns. Primary Care Psychiatry 2001;7(4):145-151.

Skaer TL, Robison LM, Sclar DA, Galin RS. Treatment of Depressive Illness Among Children and Adolescents in the United States. Current Therapeutic Research: Clinical and Experimental 2000;61(10):692-705.

Skaer TL, Robison LM, Sclar DA, Galin RS. Anxiety Disorders in the USA, 1990 to 1997: Trend in Complaint, Diagnosis, Use of Pharmacotherapy, and Diagnosis of Comorbid Depression. Clinical Drug Investigation 2000;20(4):255-265.

Skaer TL, Sclar DA, Robison LM, Galin RS. Trend in the Use of Antidepressant Pharmacotherapy and Diagnosis of Depression in the USA: An Assessment of Office-Based Visits 1990 to 1998. CNS Drugs 2000;14(6):473-481.

Skaer TL, Robison LM, Sclar DA, Galin RS. Psychiatric Comorbidity and Pharmacological Treatment Patterns Among Patients Presenting with Insomnia: An Assessment of Office-Based Encounters in the USA in 1995 and 1996. Clinical Drug Investigation 1999;18(2):161-167.

Updated 3/23/17    Back to top
photo of Tracy Skaer

Professor
Pharmacotherapy Department

tskaer@wsu.edu
509-358-7724

Office: HSB 210 M
P.O. Box 1495
Washington State University
Spokane, WA  99210-1495